STEVE ASELAGE
CIK 1221599 · Chief Executive Officer · last filed 2024-06-14
STEVE ASELAGE is a Chief Executive Officer who has filed 114 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for BCRX, was dated Jun 14, 2024. Across all open-market trades the lifetime net is −$21.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$17.93M
7
114
-$21.13M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCRX | Director | 72,659 | $8.70 | $632.1K | $65.1K | 23 | 2024-06-14 |
| Acer Therapeutics Inc. (ACER) Delisted | Director | 483,741 | $0.66 | $319.3K | $696.7K | 9 | 2023-03-16 |
| TVTX | Director | 166,419 | $52.04 | $8.66M | -$4.97M | 12 | 2022-05-12 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 233,732 | — | — | -$3.46M | 32 | 2020-11-06 |
| Acer Therapeutics Inc. (ACERW) Delisted | Director | 13,905 | — | — | $24.0K | 2 | 2017-12-18 |
| Acer Therapeutics Inc. (OPXAW) Delisted | Director | 11,905 | — | — | $0 | 1 | 2017-09-21 |
| BMRN | EVP, Chief Business Officer | 154,375 | $55.95 | $8.64M | -$13.49M | 33 | 2012-07-05 |
Recent Filings
114 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-14 | BCRX | Grant (A) | +6,820 | $0 | EDGAR |
| 2024-05-29 | BCRX | Buy (P) | +2,500 | $16.0K | EDGAR |
| 2023-11-20 | — | Disp (D) | −483,741 | $0 | |
| 2023-06-15 | BCRX | Grant (A) | +16,745 | $0 | EDGAR |
| 2023-03-16 | Acer Therapeutics Inc. (ACER) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-01 | Acer Therapeutics Inc. (ACER) Delisted | Buy (P) | +409,836 | $500.0K | EDGAR |
| 2022-06-09 | BCRX | Grant (A) | +12,866 | $0 | EDGAR |
| 2022-06-02 | BCRX | Grant (A) | +569 | $5.3K | EDGAR |
| 2022-05-12 | TVTX | Sell (S) | −2,575 | -$56.5K | EDGAR |
| 2022-03-02 | BCRX | Grant (A) | +301 | $5.0K | EDGAR |